Brain-Computer Interface

The Brain-Computer Interface (BCI) concept covers technologies that directly measure and modulate neural activity to enable communication and control between the brain and external devices. Core tracks include non‑invasive and implantable neural sensing hardware (EEG/ECoG/microelectrodes), neuromodulation systems, low‑latency signal processing and AI decoding software, neuroprosthetics and assistive communication, AR/VR and robotics integration, biocompatible materials and power, as well as safety, data, and clinical translation platforms.The sector's total market cap is 7863.43 billion USD, with a 24h change of -3.54%. Among 9 constituents, 5 are up (55.56%) and 4 are down (44.44%). The top gainer is Inspire Medical Systems, Inc. (INSP), with a 24h increase of +3.51%.BCI eased with mixed breadth, while leaders held firm. Favor high-quality, liquid names tied to clinical/regulatory catalysts; buy pullbacks selectively and add on improving earnings visibility and rate stability.